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On April 26, 2012, the Korea National Institute of Health officially held the
opening ceremony of newly dedicated biobank building, ‘National Biobank of
Korea’. The stocked biospecimens and related information have been distributed
for medical and public health researches. The Korea Biobank Project, which was
initiated in 2008, constructed the Korea Biobank Network consisting of the
National Biobank of Korea (NBK) with 17 regional biobanks in Korea. As of
December 2011, a total of 525,416 biospecimens with related information have
been secured: 325,952 biospecimens from the general population obtained
through cohort studies and 199,464 biospecimens of patients from regional bio-
banks. A large scale genomic study, Korea Association Resource (KARE) and many
researches utilized the biospecimens secured through Korea Genome Epidemi-
ology Study (KoGES) and Korea Biobank Project (KBP). Construction of ‘National
Biobank of Korea’, a dedicated biobank building at Osong means that NBK can
manage and check quality of the biospecimens with promising distribution of 26
million vials of biospecimen, which provide the infrastructure for the develop-
ment of health technology in Korea. The NBK and the National Library of Medi-
cine (to be constructed in 2014) will play a central role in future biomedical
research in Korea.1. Introduction
The human genome project has completed mapping
the human genome, and the next-generation sequencingted under the terms of the C
0) which permits unrestrict
roperly cited.
ase Control and Preventiontechnique expands the availability of personal DNA
sequencing, which increases the possibility of custom-
ized medical treatment. This means that the bottleneck
of customized medical treatment is transited from thereative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
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data/knowledge management. The role of biobanks as
an infrastructure of human biospecimen supply is
important for the development of customized medical
treatment, development of new drugs, and prevention of
diseases [1,2]. A biobank stores human biospecimens
from volunteer participants with various clinical condi-
tions, conducts quality checks, creates a database to
handle related information (e.g., clinical/epidemiolog-
ical data), and distributes biospecimens for researches
[3]. Well-documented, up-to-date epidemiological data,
along with extensive human biospecimen information
connected with clinical and biological information, are
necessary to draw statistically significant, effective
results in retrospective researches [3]. Furthermore, it is
also the role of the biobank to ensure the participants’
rights and to provide the ethical and legal framework for
the use of biospecimen in biobanks [4].
The UK biobank, one of the major population-based
biobanks, has secured biospecimens of 500,000 volun-
teers aged 45e69 years with related information and
distributed these biospecimen to researchers in 2012 [5].
The Kadoorie Study collects Chinese human bio-
specimens; the baseline survey on 0.5 million partici-
pants was completed in 2008, and follow-up resurvey
was subsequently performed [6]. In addition, many
countries including the United States, EU, Mexico, and
India, have constructed and run large-scale biobanks
with more than 200,000 participants [7]. There are
various biobank networks to draw collaboration among
biobanks and standard operating procedures (SOPs).Figure 1. Location of National biobanBiobanks such as P3G (Public Population Project in
Genomics; www.p3g.org) and BBMRI (Biobanking and
Biomolecular Resources Research Infrastructure; www.
bbmri.eu) discuss challenges and critical issues for
development, success, and business continuity for bio-
banks, and look for harmonization among biobanks
[8e10].
The Korea National Institute of Health (KNIH)
organized a task force to plan the construction of a bio-
bank in 2007 and started the Korea Biobank Project
(KBP) in 2008 to set up biobanks and a biobank
network. To systematically manage the biospecimens of
population-based cohorts, which was already carried out
and run in the KNIH, and collect biospecimens for
chronic diseases and rare diseases such as cancers,
diabetes, and hypertension, the Korea Biobank Network
was established including the National Biobank of
Korea (NBK) and 17 regional biobanks within 17
university hospitals (Figure 1).
This report discusses the details of the 2008e2012
biobank construction in Korea (the first term of the
KBP) and major achievements (e.g., biospecimen
collection and creation of database) along with
a description of the facilities and instruments used in the
NBK, and to share the experience in running a large-
scale human biospecimen network.
2. Overview of the Korea Biobank Project
The KBP’s (first term, 2008e2012) aim was to
secure a total of 500,000 Korean human biospecimensk and regiononal biobanks in Korea.
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population and 200,000 from diseased participants). The
NBK secured the general population’s biospecimens
from various cohorts organized by the KNIH since 2001.
Regional biobanks secured disease-based biospecimens
in 17 university hospitals, representing diseases such as
cancers, chronic diseases, and rare diseases. As of
December 2011, a total of 525,416 specimens (325,952
from the general population and 199,464 from diseased
populations) have been secured, reaching the first term’s
goal 1 year early (Figure 2).
When KBP began in 2008, eight regional biobanks
were established; four, one, and four additional regional
biobanks were constructed in 2009, 2010, and 2011,
respectively. Each regional bank can perform an inde-
pendent biobank function to secure, store, and distribute
by input of standardized human biospecimen informa-
tion and clinical information under Biospecimen Infor-
mation Management System (BIMS), run by NBK. The
second term (2013e2015) plans to provide the user-
friendly, one-stop distribution service of KBN in
a coordination center.
NBK’s functions include securing and distributing
population-based cohort biospecimens, planning of the
KBP project, providing education for regional biobank
staffs, handling public relations, and construction and
running of BIMS and the KBP portal site (http://kbn.
cdc.go.kr).3. Status of Population-based Human
Biospecimens
The population-based human biospecimens come
from population-based cohorts, separately run by the
KNIH (Division of Epidemiology and Health Index,
Division of Health and Nutrition Examination Survey),Figure 2. Number of participincluding the Korean Genome Epidemiology Study
(KoGES), Korea National Health and Nutrition Exami-
nation Survey, and research projects of the KNIH such
as Polycystic Ovarian Syndrome Cohort and AIDS
Cohort (Table 1).
KoGES is a large-scale Korean genome epidemi-
ology cohort with 220,000 participants as of 2012.
The cohort started from the AnsungeAnsan
Community-based Cohort in 2001. The community-
based cohort is composed of 10,038 participants aged
40e69 years (5,020 in Ansan, 5,018 in Ansung); it
distributes questionnaires and performs biospecimen
collection and physical examination every 2 years.
About 2,000 items for each person are collected
including lifestyle, medical history, physical activity,
food consumption, disease-related blood test results
and body measurement. The information and bio-
specimens from the rural Ansung community and
urban Ansan community cohort are utilized in
analytical studies on interaction of risk factors of
chronic diseases and genomic characteristics and
observational studies on environmental risk factors.
The fifth follow-up examination was completed in
2011, and now the sixth follow-up examination is
under progress (http://biomi.cdc.go.kr).
The production of human biospecimens is conducted
by a company contracted with NBK. Blood samples
from the nationwide collection sites using preconfirmed
standard protocol are transported by vehicles equipped
with refrigerators (set at 4 C) and thermal monitoring
systems, and are turned into biospecimens of blood
plasma, serum, and DNA and temporarily stored at
80 C. Next, the biospecimens in refrigerators are
transported to NBK and undergo examination and
quality check, then classified and stored according to
SOPs into three classes: for distribution, backup, or
permanent reference.ants in biobanks in Korea.
Table 1. Status of cohorts in Korea National Institute of Health (as of Jan. 2012)
Category Cohort Participant(s)
Korean Genome and Epidemiology Study Population-Based Cohort 225,850




Disease Prevention Research The Korea National Health & Nutrition Examination
Survey
46,127
National Infectious Disease Serosurveillance Study 2,139
Subtotal 48,266
Immunology and Communicable Disease Research National Measles Serosurveillance Study 16,251
National Brucellosis Survey 7,439
AIDS Cohort 1,072
Subtotal 24,762
Genome and Biomedical Science Research Polycystic Ovarian Syndrome Cohort/Genome
Research
2,704
Major Birth Defect Cohort 2,533
Korea Longitudinal Study of Aging 911
Avellino Cohort 871
Polycystic Ovarian Syndrome Cohort/Biomedical
Science Research
633
Primary Care Family Cohort 514
Subtotal 8,166
Total 352,952
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including community-based cohorts, 10 vials of 300 mL
of blood plasma and serum from a participant are
collected and stored at 185C, blood DNA of
80e100 mg collected from whole blood is divided into
two sets of 20-mg vials, and the rest of the DNA is put
into one vial and stored at e75C. Midstream urine of
10 mL is collected and put into a 15-mL conical tube
and stored at 75C. For maximizing the efficacy of
distribution, the automated biospecimen storage and
distribution system operate with 300,000 vials of DNA.
The numbers and types of biospecimens secured in
the first term of KBP are shown in Figure 3. A total of
5,268,716 vials and tube of human biospecimen have
been secured: 2,078,544 sera, 1,953,270 plasmas,
801,309 DNAs, and 435,593 others [including urine and
lymphoblastoid cell line (LCL), B-cell]. The humanFigure 3. Total number of collected biobiospecimens have been utilized in an intramural
research of KNIH, Korean Association Resource
(KARE) project, and also on extramural research.4. Status of Disease-related Human
Biospecimens
KBP’s disease-related human biospecimens are
secured through 17 regional biobanks located in 17
university hospitals. Figure 4 shows the number and type
of biospecimens obtained from the first-term KBP in 17
regional biobanks. The proportion of neoplastic diseases is
45%, whereas that of non-neoplastic diseases is 55%. The
characteristic of a regional biobank determines the kinds
of biospecimens that are collected. For example, Kyung-
sang University Hospital specializes in childhoodspecimens in KBP (as of Dec. 2011).
Figure 4. Number of disease participants in regional biobanks of Korea Biobank Network. Disease categories : KCD-6 (Korean
Standard Classification of Disease), Unit : Participants.
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University Hospital concentrates on intractable geriatric
diseases,Wonkwang University Hospital places emphasis
on immune diseases and gastric disease, and Soon-
chunhyang University specializes in asthma and lung
diseases. The kind of biospecimens collected on cancer
and chronic diseases depends on the hospitals in which the
regional biobanks are located. The paired biospecimens of
cancer and normal tissues are common biospecimens in all
regional biobanks and stored in paraffin block, optimal
cutting temperature block, and fresh frozen forms.
The information on a disease-related biospecimen
found in the EMR (Electronic Medical Record) in
a hospital synchronizes with that in BIMS, and auto-
matically inputs the predefined items into BIMS in some
biobanks. For reference in this procedure, Biobank Data
Dictionary, which NBK has developed and distributed,
is used for understanding and systematic and consistent
integration of terminology. All information on partici-
pants is made anonymous to protect their identity and
guidelines on research ethics are strictly followed.
As of December 2011, the regional biobanks have
amassed a total of 2,572,452 vials: 1,274,313 plasmas,
568,041 sera, 222,872 tissues, 143,667 buffy coats, and
318,559 others (DNA, urine and LCL) (Figure 3).Figure 5. Number of distributed biospecimens (2001e2011).5. Status and Results of the Distribution
in the First Term KBP
The first term KBP (2008e2012) focuses on securing
Korean human biospecimens and constructing and
running the network. Since 2001, when biospecimen
distribution of KNIH started, until the end of 2011
(when the first term of KBP ended), collected bio-
specimen and information have been distributed for
a total of 454 research projects: 117 projects from NBKs
and 347 projects from regional biobanks.
DNA biospecimen distribution takes the lion’s share
(163,939, or 87%) of the total number of distributions(188,380). It is followed by distribution of serum
(14,971, 8%), plasma (6,515, 3%), and other specimens
including cells (2,958, 1.6%) (Figure 5). Most studies
have been conducted by using poplubation-based human
biospecimens of the Ansan and Ansung Cohort [11]. A
large-scale genomic study, the Korean Association
Resource (KARE) project, analyzed GWAS (genome-
wide association study) utilizing 8,842 Korean genomic
DNA samples secured through KoGES and KBP, and
reported the identified genomes related to hypertension,
the waist/hip ratio, and bone mineral density [12]. In
2011, Cho found and reported the common loci for
metabolic diseases in East Asians after a large-scale
GWAS analysis such as repetitive comparison analysis
of 30,395 participants’ DNA using Korean Association
Resource and the Health Examinee cohorts with Bio-
Bank Japan genome-wide association study and Health2
and Shanghai Jiao Tong University Diabetes Cohort in
China [13]. The information and biospecimens, which
were distributed to cohort researchers and general
researchers, made it possible to identify the diet patterns
causing certain diseases [14], index of sleeping pattern
182 S.Y. Cho, et al(e.g., snoring) [15], and genome relating to the height of
Koreans [16].
As the KBP continues to operate, requests for
distribution increase. The automated biospecimen
storage and distribution system was introduced for quick
distribution of preserved biospecimens. The system has
distributed 33,331 biospecimens since its launching in
June 2010.
A total of 89 papers have been produced through the
studies using distributed human biospecimens from
NBK: 11 intramural research studies from the KNIH, 18
extramural research, and 60 collaboration researches
(Figure 6).6. Quality Check of Biospecimens in KBN
The standardization of management on human bio-
specimen, the manual, regulations, guidelines for bio-
specimen distribution, and working-level guidelines are
documented in “Work about Collection, Storage,
Distribution of Biospecimens,” which obtained ISO
9001:2008 quality management system accreditation
from the Korea Standard Association in November 2005
and has maintained this accreditation status with peri-
odic post-evaluations.
Quality assurance on human biospecimens consists of
DNA stability test by electrophoresis, DNA purity test
by spectrophotometer, microorganism contamination
test by polymerase chain reaction, cross-contamination
test by analysis of homogeneity. All biospecimens
collected in KoGES undergo DNA degradation test andFigure 6. Total number of pubpurity test, and the quality assured data with bio-
specimens are saved. Ten percent of stocked bio-
specimens are randomly selected and tested for the
quality assurance test to ensure good quality of DNA
biospecimens. The same is true for LCL quality assur-
ance; 10% of the stocked biospecimens are randomly
selected to undergo survival rate investigation with
cross-contamination test.7. Opening of Newly Constructed NBK
Building and Facilities
Construction of the NBK was finally completed
(areaZ 12,301 m2), and the opening ceremony was
held on April 26, 2012 at the Osong Health Technology
and Administration Complex, Chungcheongbuk-do,
Korea (Figure 7). The three-story building including
a basement houses storage rooms that can contain 26
million vials of biospecimens; this volume is expected to
increase as soon as the automated large archive and
related facilities will be installed. The structure also
houses laboratories (for quality assurance of bio-
specimen and pathogens), an auditorium with 150 seats,
a main video conference room, nine conference rooms,
and staff offices. The budget for the project was secured
from the Korean central government in 2008, and it took
24 months to complete the construction (starting from
April 2010), shortly followed by a preliminary operation
period.
As of 2012, NBK has used two different types of
freezer to store the biospecimens steadily for a longlications (As of Dec. 2011).
Figure 7. Sectors in the National Biobank of Korea.
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172 liquid nitrogen containers (working temperature:
185C). Those freezers are racked to maximize the
storage space and to distribute the biospecimens effi-
ciently. One deep freezer stores 48,600 vials of DNA
biospecimens or 8,640 urine biospecimens, while one
liquid nitrogen container holds 34,600 or 70,000 vials of
sera and plasma. The automated biospecimen storage
and distribution system administers 300,000 vials of
specimens to maximize the distribution of
biospecimens.
The main storage rooms (an area of 3,202 m2) consist
of two floors; the first floor is for the deep freezers while
the second floor is for the liquid nitrogen containers. The
backup storage space is 1,256 m2. The current storage
space holds a maximum of 219 deep freezers and 544
liquid nitrogen containers with a maximum storage
capacity of 25,357,540 vials of human biospecimen. If
the planned automated large archive is installed, the
capacity will expand drastically.
The main storage equipment, such as deep freezers,
are electrically operated with mechanical compressors,
so that the backup is available in case of power failure or
malfunction. All deep freezers are equipped with an
automated voltage regulator; if it experiences malfunc-
tion, the operator will be notified by the temperature
monitoring system. In case of a power failure, a liquid
nitrogen backup system is available. Two 600-KW
emergency generators are designed to maintain themaximum number of deep freezers and liquid nitrogen
containers. An additional option is provided by means of
a separate oil tank, which can operate for 48 consecutive
hours.
To prevent the possible occurrence of suffocation
among the staff (as a result of the use of large-scale
liquid nitrogen containers), each storage room is
equipped with a measuring device to measure oxygen
concentration; the concentration of oxygen is displayed
outside the room. Inside the room, double ventilation
and air-conditioning system are always turned on. In
case of fire, the automated fire extinguisher system is
designed to disperse inert gas (HFC-23) to avoid
harming the equipment or biospecimens. Closed-caption
TVs are installed inside and outside the building with
a 24-hour, 7-day continuous video-recording system to
protect the facilities and information.8. Conclusion
A biobank is an indispensible infrastructure of the
post-genome era and continues to evolve in a sophisti-
cated manner. To facilitate the next generation of
genome studies for customized medicine and develop-
ment of biomarkers, the support of an advanced biobank
is necessary. To enhance the quality and availability of
specimens, a biobank network system is run, and the
networking will be even more enhanced. In the future,
184 S.Y. Cho, et althe SOPs and guidelines suggested by this network will
dominate the biobank management and research on
biobank specimens. To keep up with this trend, the NBK
has obtained accreditation of biobank management
system (ISO 9001: 2008) and the establishment of
human biospecimen management standard protocol, so
that it can enhance the stability and quality of specimens
by constructing NBK with 17 regional biobanks and
ensuring good quality specimen and information. With
the introduction of an automated biospecimen storage
and distribution system, the NBK enhances the precision
and efficiency of the distribution of human bio-
specimens, and continues to develop quality assurance
techniques and research on the utilization of bio-
specimens. In the future, the NBK will not only partic-
ipate in domestic and international biobank networks,
but will also seek to encourage the standardization of
biospecimen quality and harmonization of biobanks. By
doing so, it seeks to promote biomedical researches for
the genome protein study to treat and prevent diseases,
as well as the development of new medicines, that will
eventually lead to realizing customized medical
treatment.
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